McNaught, Kevin St. P.

Proteasomal function is impaired in substantia nigra in Parkinson’s disease

McNaught, K. S. P., & Jenner, P. (2001) · Neuroscience Letters

Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathways

Cited by 653

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

McNaught, K. S. P., Perl, D. P., Brownell, A., & Olanow, C. W. (2004) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 548

Failure of the ubiquitin-proteasome system in Parkinson’s disease

McNaught, K. S. P., Olanow, C. W., Halliwell, B., Isacson, O., & Jenner, P. (2001) · Nature Reviews Neuroscience

Parkinson's Disease Mechanisms and TreatmentsUbiquitin and proteasome pathways

Cited by 519

Proteolytic stress: A unifying concept for the etiopathogenesis of Parkinson’s disease

McNaught, K. S. P., & Olanow, C. W. (2003) · Annals of Neurology

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 203

Advances in understanding and treatment of Tourette syndrome

McNaught, K. S. P., & Mink, J. W. (2011) · Nature Reviews Neurology

Obsessive-Compulsive Spectrum DisordersDeep Brain Stimulation and Movement Disorders

Cited by 196